Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for OCPNF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for OCPNF and 80,000+ other tickers.
See exactly how OCPNF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for OCPNF and 80,000+ other tickers.
Established in Tokyo, Japan, in 1919, Olympus Corporation is a global leader in the manufacturing and distribution of advanced precision machinery and scientific instruments. The company structures its diverse operations into four main segments. Its Endoscopic Solutions division provides sophisticated endoscopic tools for gastrointestinal and surgical procedures, along with complete endoscopy systems and crucial repair services. The Therapeutic Solutions segment delivers specialized medical devices for urology, gynecology, and otolaryngology (ear, nose, and throat), alongside endo-therapy and…
Olympus Corporation (OLYMY) Q3 2026 Earnings Call Transcript
Olympus Corporation (OLYMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Olympus Corporation (OTCPK:OLYMY) Discusses New Strategic Vision and Expansion of Endoscopy-Enabled Care November 6, 2025 7:00 PM EST Company Participants Presentation Unknown Executive Today marks an exciting milestone, sharing with you the new Olympus strategy, one that builds on our evolution as a pure-play med tech company, but also defines the next chapter with clarity and conviction. Let us begin with the world around us.
Olympus Corporation (OTCPK:OLYMY) Q1 2026 Earnings Conference Call August 8, 2025 2:00 AM ET Company Participants Bob White - Director, Representative Executive Officer, President and Chief Executive Officer Boris Shkolnik - Executive Officer and Chief Quality Officer Frank Drewalowski - Executive Officer of Gastrointestinal Solutions Seiji Kuramoto - Executive Officer and Surgical and Interventional Solutions Tatsuya Izumi - Executive Officer and Chief Financial Officer Conference Call Participants Bob White Hello, everyone. Thank you for joining us today for our FY2026 Q1 earnings call.
Olympus Corporation (OTCPK:OLYMY) Q4 2025 Earnings Conference Call May 13, 2025 2:00 AM ET Company Participants Yasuo Takeuchi - Director, Representative Executive Officer, Executive Chairperson & ESG Officer Tatsuya Izumi - Chief Financial Officer Frank Drewalowski - Executive Officer & Endoscopic Solutions Division Head Seiji Kuramoto - Executive Officer & Therapeutic Solutions Division Head Conference Call Participants Yasuo Takeuchi Hello everyone. I am Takeuchi, Representative Executive Officer.